Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page.
A test that detects an autoimmune response to gluten that targets the brain could increase understanding of neurological complications in those who have celiac disease and other gluten-related disorders.
AVALON is a Phase 1 clinical trial that aims to assess the safety and tolerability of VTP-1000, a potential treatment for celiac disease. VTP-1000 is a targeted immunotherapy designed to prevent or reduce symptoms of celiac disease from accidental gluten exposure by promoting tolerance to gluten.
Even those who have high-risk conditions for celiac disease face long delays in getting diagnosed, according to a study by Weil Cornell Medicine and Beyond Celiac published recently in the Journal of Clinical Medicine.
In IBS patients, celiac disease diagnosis may be being missed in some cases, while in others the gluten-free diet may not be necessary, according to two new studies.
A Phase 2 clinical trial is testing a potential treatment, Amlitelimab, for celiac disease. Amlitelimab is a monoclonal antibody that is proposed to work in celiac disease by interrupting the immune response that occurs.
A new test developed by researchers in Australia has shown promising results in detecting a response to gluten in blood even when someone is on a gluten-free diet. Additionally, the test has the potential to eliminate the need for a biopsy to definitively diagnose celiac disease.
Breastfeeding in early infancy, the amount of gluten a baby consumes daily, as well as nationality, sex and birth order are environmental factors that influence whether at-risk children go on to develop celiac disease.
In celiac disease, changes in the gut that persist even on a gluten-free diet may lead to an immune “scar” that could be the cause of ongoing symptoms, new research funded by Beyond Celiac has found.
Even those who have high-risk conditions for celiac disease face long delays in getting diagnosed, according to a study presented at Digestive Disease Week (DDW) by Weil Cornell Medicine and Beyond Celiac.
If you have celiac disease, get ready to pucker up without fear that kissing will expose you to gluten. A new study by researchers at Columbia University found that there is little risk of getting cross-contaminated by gluten through kissing.
Results from a clinical trial for a new drug to treat celiac disease by preventing an immune reaction to gluten with the use of nanoparticles were shared for the first time Monday at Digestive Disease Week (DDW).
Neurological symptoms of celiac disease are less well known than gastrointestinal symptoms such as diarrhea and abdominal pain. Beyond Celiac conducted a study on neurological symptoms and presented it at AAN to draw neurologists’ attention to symptoms that might not be recognized as signs of celiac disease in their patients.
Even those with celiac disease who follow the gluten-free diet and have healing of their intestines sometimes continue to have anemia, a recent study found
Beyond Celiac has granted a three-year Established Investigator Grant to the University of Sheffield, Sheffield UK, continuing the organization’s support for research into neurological symptoms of celiac disease and other gluten-related disorders.
Beyond Celiac original research selected for presentation at DDW for the fifth time and fourth consecutive year.
In the digital age, it’s easy for information to get lost in the flood of a feed. To catch you up to speed, we’re sharing the top celiac disease research stories of 2024, based on visits from community members like you.
When you are diagnosed with celiac disease at 60 years or more, your chance of being frail increases both before and after diagnosis, according to a recent study.
Only 10 percent of nearly 224,000 children who had a symptom or condition that should have led to celiac disease testing were actually tested, Beyond Celiac research found.
Beyond Celiac recently presented three posters that provide evidence that screening for celiac disease is not taking place as often as it should, that neurological symptoms are frequent and severe and that those with celiac disease are often exposed to gluten, which impacts their social interactions and work.
Beyond Celiac and the American Gastroenterological Associate partnered to bring important updates in celiac disease research, management and more to patients through patient-friendly summaries of recent articles published by AGA.
For those with celiac disease, an endoscopy and biopsy may not be a major barrier to participating in clinical trials and intestinal healing is an important result when celiac disease patients consider potential treatments, Beyond Celiac research finds.
Nearly one in four non-Hispanic Black Americans who have conditions that should lead to a test for celiac disease never get one, according to data presented by Beyond Celiac at the International Celiac Disease Symposium.
The answers to how and where the response to gluten in celiac disease begins have been found in the single layer of cells that line the small intestine, according to new research led by McMaster University researchers.
Who’s missing in celiac disease diagnosis and what patients want in clinical trials among Beyond Celiac topics to be presented at upcoming international celiac disease meeting in Sheffield, UK.
A new study that analyzed the activity of more than 10,000 genes found that a drug being investigated to treat celiac disease prevented intestinal damage caused by gluten.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
